A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers

Clinical trial NCT04983368 · COMPLETED

Trial details

NCT number: NCT04983368
Sponsor: Actinogen Medical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Alzheimer's Disease

Start date: 2021-06-30
Primary completion: 2022-02-11
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.